Home
About
Overview
Sharing Data
ORCID
Help
History (1)
PARP inhibition in the ovarian cancer patient: Current approvals and future directions.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
PARP inhibition in the ovarian cancer patient: Current approvals and future directions.
PARP inhibition in the ovarian cancer patient: Current approvals and future directions. Pharmacol Ther. 2020 09; 213:107588.
View in:
PubMed
subject areas
Antineoplastic Agents
Biomarkers, Tumor
Female
Humans
Neoplasm Recurrence, Local
Ovarian Neoplasms
Poly(ADP-ribose) Polymerase Inhibitors
Poly(ADP-ribose) Polymerases
authors with profiles
Katherine Kurnit